Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI). (Indego)

June 26, 2017 updated by: Parker Hannifin Corporation
This study will evaluate the Indego® device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Englewood, Colorado, United States, 80113
        • Craig Hospital
    • Georgia
      • Atlanta, Georgia, United States, 30309
        • Shepherd Center
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Rehabilitation Institue of Chicago
    • New Jersey
      • West Orange, New Jersey, United States, 07052
        • Kessler Institute for Rehabilitation
    • New York
      • New York, New York, United States, 10016
        • Rusk Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be 18 years or older
  • Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length).
  • Hip width as measured in sitting no greater than 16.6" (42 cm) (acceptable hip width may vary depending on soft tissue).
  • Femur length as measured in sitting must be between 14 inches (35.5cm) and 18.5 inches (47 cm)
  • Weight 250lbs (113.4 kg) or less
  • Present with Spinal Cord Injury and NLI C5 and lower, with ISNCSCI A, B, C or D who are non-ambulatory or poorly ambulatory.
  • There are no restrictions on time since injury. However, each subject must have signed medical clearance/approval for full weight bearing and locomotor training.
  • Determined to have sufficient bone health for walking with full weight bearing without undue risk for fracture. Meeting of this criterion is at the discretion of each subject's personal MD and must be approved by each site's Medical PI.
  • Passive range of motion (PROM) at shoulders, trunk, upper extremities and lower extremities within functional limits for safe gait and use of appropriate assistive device/stability aid.
  • Skin must be intact where it interfaces with robotic device
  • Modified Ashworth Scale for spasticity score must be 3 or less.
  • Blood pressure and heart rate within established guidelines for locomotor training:

    • At rest; Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
    • Exercise; Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
  • Tolerate being in an upright standing position (passive or active) without being lightheaded or having a headache.

Exclusion Criteria:

  • Weight in excess of 250 lbs
  • Heterotopic ossification that, in the opinion of the investigator, would place the subject at undue risk for fracture.
  • Any subject deemed at increased risk for injury by Medical Personnel
  • Lower extremity joint limitation that exceeds 10 degrees at their hips, knees or ankles.
  • Light headedness or headache in standing position (active or passive)
  • Moderate to Severe Traumatic (or Acquired) Brain Injury
  • Inability to follow instructions
  • Colostomy bag
  • Women who are pregnant or attempting to become pregnant during the study intervention.
  • Unable to obtain informed consent (either from the subject or from the subjects Legally Authorized Representative).
  • Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol specified assessments
  • Unlikely to be available for follow-up phone call.
  • Any other issue which, in the opinion of the investigators, will make the subject unsuitable for study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Indego
Indego

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Subjects Able to Complete the 600 Meter Walk Test (600MWT)
Time Frame: 8 weeks
Measured time for an individual to complete walking 600 meters on a level surface with the Indego and stability aid at the end of the study, proposed to be representative of an individual's ability to ambulate in the community.
8 weeks
Average Speed of 10 Meter Walk Test (10MWT) Mid Study Versus End of Study
Time Frame: 4 weeks, 8 weeks
Measured time for an individual to complete walking 10 meters with the Indego and a stability aid midway through the study and at the end of the study.
4 weeks, 8 weeks
Timed Up and Go (TUG) Test
Time Frame: 8 weeks
Measures the time required for an individual to stand from a seated position, walk three meters, turn, walk back three meters, turn and return to a seated position.
8 weeks
Average Time to Don/Doff Device
Time Frame: 8 weeks
Time needed for an individual to don or doff the device.
8 weeks
Percentage of Subjects That Could Don/Doff the Device Independently
Time Frame: 8 weeks
The percentage of participants that could don/doff the device independently at the end of the study, without the help of their Physical Therapist.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking Index for Spinal Cord Injury (WISCI-II) Assessment
Time Frame: 8 weeks

Assesses physical assistance and devices required for persons to walk following paralysis resulting from a Spinal Cord Injury.

0:unable

  1. parallel bars, braces, help of 2 persons,<10m
  2. parallel bars, braces, help of 2 persons,10m
  3. parallel bars, braces, help of 1 person,10m
  4. parallel bars, no braces, help of 1 person,10m
  5. parallel bars, braces, no help,10m
  6. walker, braces, help of 1 person,10m 7:2 crutches, braces, help of 1 person,10m

8:walker, no braces, help of 1 person,10m 9:walker, braces, no help,10m 10:1 cane/crutch, braces, help of 1 person,10m 11:2 crutches, no braces, help of 1 person,10m 12:2 crutches, braces, no help,10m 13:walker, no braces/help,10m 14:1 cane/crutch, no braces, help of 1 person,10m 15:1 cane/crutch, braces, no help,10m 16:2 crutches, no braces/help,10m 17:no devices/braces, help of 1 person,10m 18: no devices, braces, no help,10m 19:1cane/crutch, no braces/help,10m 20:no devices/braces/help,10m

Reference: rehabmeasures.org

8 weeks
Functional Independence Measure (FIM) Score for Walking Indoors
Time Frame: 8 weeks

FIM measures an individual's level of disability and indicates how much assistance is needed for that individual to carry out activities of daily living.

7: complete independence 6: modified independence 5: supervision or setup assistance 4: minimal contact assistance 3: moderate assistance 2: maximal assistance

1: total assistance

Reference: rehabmeasures.org

8 weeks
Borg Rating of Perceived Exertion (BRPE) for Walking Indoors
Time Frame: 8 weeks

The BPRE characterizes the level of effort required by an individual to perform a task and takes into account both the person's fitness level and the difficulty of the task.

6: no exertion at all 7: extremely light 8-9: very light 10-11: light 12-13: somewhat hard 14-15: hard (heavy) 16-17: very hard 18-19: extremely hard 20: maximal exertion

8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

July 23, 2014

First Submitted That Met QC Criteria

July 25, 2014

First Posted (Estimate)

July 29, 2014

Study Record Updates

Last Update Posted (Actual)

July 25, 2017

Last Update Submitted That Met QC Criteria

June 26, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injury

Clinical Trials on Indego

Subscribe